Winter

Zymosan belongs to the group of biogenic agents. Its international name is Zymozan. This drug is also known under the synonym "Zymozan suspension".

Zymosan is a suspension of the cell walls of the yeast Saccharomyces cerevisiae. It has immunostimulating, anti-inflammatory and detoxifying effects.

The drug stimulates phagocytosis, enhances the production of interferon and the activity of natural killer cells. Zymosan increases the body's nonspecific resistance to infections.

Zymosan is used for the treatment and prevention of viral, bacterial and fungal infections, in the complex therapy of malignant neoplasms.

The drug is released in the form of a suspension for injection and oral use. The recommended dose and duration of treatment depend on the indications and are prescribed by the doctor individually.